Keating Financial Advisory Services’s Terns Pharmaceuticals TERN Stock Holding History

Keating Financial Advisory Services’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1	Closed	-$53	–	2708
2026 Q1	$53	Buy	+1	New	+$41	﹤0.01%	2447

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Keating Financial Advisory Services's TERN Position: Q2 2026 in Review

Keating Financial Advisory Services sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 1 share — an estimated $53 sold.

Keating Financial Advisory Services first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $53 in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Keating Financial Advisory Services reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Keating Financial Advisory Services sold 1 Terns Pharmaceuticals share in Q2 2026, an estimated $53.
Keating Financial Advisory Services first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Keating Financial Advisory Services's Terns Pharmaceuticals position peaked at $53 in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Keating Financial Advisory Services's 13F filing for Q2 2026, filed 11 Aug 2026.